Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dihydro-1h-pyrrolo(1,2-a)imidazole-2,5-(3h,6h)-dione
1. 126100-97-8
2. Dimiracetam [inn]
3. Dihydro-1h-pyrrolo[1,2-a]imidazole-2,5(3h,6h)-dione
4. Tetrahydro-5h-pyrrolo[1,2-a]imidazole-2,5(3h)-dione
5. 4aw7f70mzo
6. Nt-11624
7. Dihydro-1h-pyrrolo(1,2-a)imidazole-2,5(3h,6h)-dione
8. 1h-pyrrolo(1,2-a)imidazole-2,5(3h,6h)-dione, Dihydro-
9. Nt 11624
10. Unii-4aw7f70mzo
11. 3,6,7,7a-tetrahydro-1h-pyrrolo[1,2-a]imidazole-2,5-dione
12. (+-)-dihydro-1h-pyrrolo(1,2-a)imidazole-2,5(3h,6h)-dione
13. Schembl195256
14. Chembl337612
15. Dtxsid20869732
16. Bfa10097
17. Mfcd00867777
18. Akos006272567
19. Db13018
20. Sb17242
21. Ac-32019
22. As-56333
23. Cs-0026742
24. Tetrahydro-pyrrolo[1,2-a]imidazole-2,5-dione
25. W17118
26. 2,5-dioxohexahydro-1h-pyrrolo[1,2-a]imidazole
27. 2.5-dioxohexahydro-1h-pyrrolo[1,2-a]imidazole
28. 2,5-dioxohexahydro-1-h-pyrrolo[1,2-a]imidazole
29. Hexahydro-1h-pyrrolo[1,2-a]imidazole-2,5-dione
30. Q3707748
31. Hexahydro-1h-pyrrolo[1,2-a]imidazolidine-2,5-dione
32. (+/-)-dihydro-1h-pyrrolo(1,2-a)imidazole-2,5(3h,6h)-dione
| Molecular Weight | 140.14 g/mol |
|---|---|
| Molecular Formula | C6H8N2O2 |
| XLogP3 | -0.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 140.058577502 g/mol |
| Monoisotopic Mass | 140.058577502 g/mol |
| Topological Polar Surface Area | 49.4 Ų |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Complexity | 202 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Dimiracetam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dimiracetam, including repackagers and relabelers. The FDA regulates Dimiracetam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dimiracetam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dimiracetam supplier is an individual or a company that provides Dimiracetam active pharmaceutical ingredient (API) or Dimiracetam finished formulations upon request. The Dimiracetam suppliers may include Dimiracetam API manufacturers, exporters, distributors and traders.
click here to find a list of Dimiracetam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dimiracetam DMF (Drug Master File) is a document detailing the whole manufacturing process of Dimiracetam active pharmaceutical ingredient (API) in detail. Different forms of Dimiracetam DMFs exist exist since differing nations have different regulations, such as Dimiracetam USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dimiracetam DMF submitted to regulatory agencies in the US is known as a USDMF. Dimiracetam USDMF includes data on Dimiracetam's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dimiracetam USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dimiracetam suppliers with USDMF on PharmaCompass.
Dimiracetam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dimiracetam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dimiracetam GMP manufacturer or Dimiracetam GMP API supplier for your needs.
A Dimiracetam CoA (Certificate of Analysis) is a formal document that attests to Dimiracetam's compliance with Dimiracetam specifications and serves as a tool for batch-level quality control.
Dimiracetam CoA mostly includes findings from lab analyses of a specific batch. For each Dimiracetam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dimiracetam may be tested according to a variety of international standards, such as European Pharmacopoeia (Dimiracetam EP), Dimiracetam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dimiracetam USP).
LOOKING FOR A SUPPLIER?
